Israel Blood Disease Industry Outlook 2022 - 2026

See how Israel Blood Disease performed compared to key markets such as France, Germany and the United Kingdom.

Key Market Indicators

The prevalence of anemia in Israel is expected to reach 11,200 hospital discharges by 2026. This is a slight increase of 0.3% per year from the 11,020 hospital discharges recorded in 2021. Since 2005, the demand for anemia care in Israel has decreased by 0.1% each year. In 2021, Austria had the highest number of hospital discharges for anemia, at 11,020. Germany, the UK and Poland respectively followed at numbers 2, 3 and 4.

Israel Blood Disease Market Data and Forecasts

How much will Israel Blood Disease Market grow to 2026?

Forecast: Prevalence of Anemia in Israel
Forecast: Hospital Discharges for Anaemias Cases in Israel
Forecast: Hospital Discharges for Anaemias Cases in Israel
Forecast: Prevalence of Anemia in Israel

Other Top Countries about Blood Disease